Difference between revisions of "Cribriform pattern within invasive prostate carcinoma"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
'''Cribriform pattern within invasive prostate carcinoma''' has been shown to be poor prognosticator in [[prostate cancer]].<ref>{{Cite journal | last1 = Iczkowski | first1 = KA. | last2 = Paner | first2 = GP. | last3 = Van der Kwast | first3 = T. | title = The New Realization About Cribriform Prostate Cancer. | journal = Adv Anat Pathol | volume = 25 | issue = 1 | pages = 31-37 | month = Jan | year = 2018 | doi = 10.1097/PAP.0000000000000168 | PMID = 28820750 }}</ref> | '''Cribriform pattern within invasive prostate carcinoma''' has been shown to be poor prognosticator in [[prostate cancer]].<ref>{{Cite journal | last1 = Iczkowski | first1 = KA. | last2 = Paner | first2 = GP. | last3 = Van der Kwast | first3 = T. | title = The New Realization About Cribriform Prostate Cancer. | journal = Adv Anat Pathol | volume = 25 | issue = 1 | pages = 31-37 | month = Jan | year = 2018 | doi = 10.1097/PAP.0000000000000168 | PMID = 28820750 }}</ref> | ||
==General== | |||
In the morphologic context, ''invasive cribriform carcinoma'' may be lumped with ''intraductal carcinoma of the prostate'', as immunostains are required to differentiate.<ref name=pmid28530220>{{cite journal |vauthors=Kweldam CF, Kümmerlin IP, Nieboer D, Steyerberg EW, Bangma CH, Incrocci L, van der Kwast TH, Roobol MJ, van Leenders GJ |title=Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4&#61;7 prostate cancer |journal=Mod. Pathol. |volume=30 |issue=8 |pages=1126–1132 |date=August 2017 |pmid=28530220 |doi=10.1038/modpathol.2017.29 |url=}}</ref> | |||
==Microscopic== | |||
Features:{{fact}} | |||
*Cribriform architecture. | |||
*Loss of basal cells. | |||
==See also== | ==See also== | ||
Revision as of 17:25, 11 September 2020
Cribriform pattern within invasive prostate carcinoma has been shown to be poor prognosticator in prostate cancer.[1]
General
In the morphologic context, invasive cribriform carcinoma may be lumped with intraductal carcinoma of the prostate, as immunostains are required to differentiate.[2]
Microscopic
Features:[citation needed]
- Cribriform architecture.
- Loss of basal cells.
See also
References
- ↑ Iczkowski, KA.; Paner, GP.; Van der Kwast, T. (Jan 2018). "The New Realization About Cribriform Prostate Cancer.". Adv Anat Pathol 25 (1): 31-37. doi:10.1097/PAP.0000000000000168. PMID 28820750.
- ↑ "Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer". Mod. Pathol. 30 (8): 1126–1132. August 2017. doi:10.1038/modpathol.2017.29. PMID 28530220.